Industry win asWHO lists broad-spectrum sunscreen as Essential Medicine
In a landmark move for public health, the World Health Organization (WHO) has added broad-spectrum sunscreen with high SPF to the 24th edition of the Model List of Essential Medicines. The decision, supported by BASF and Beyond Suncare, underscores sunscreen’s critical role in preventing skin cancer, premature aging, and other sun-related health risks. This expansion of the Essential Medicines list reflects a growing recognition that sun protection is a fundamental health intervention, accessible to populations worldwide.
What this decision means for public health
Broad-spectrum sunscreen protects against both UVA and UVB rays, reducing the risk of malignant melanoma and other skin cancers while also helping prevent photoaging. By classifying these products as Essential Medicines, the WHO signals that sun protection should be prioritized in national health policies and funding decisions. This move aims to improve equity in access to effective sun care, particularly in regions with high UV exposure and limited healthcare resources.
Implications for healthcare systems and policy
Health ministries and insurance providers may increasingly consider the inclusion of high-SPF, broad-spectrum sunscreens in public health programs. The designation could drive subsidies, school-based skin cancer prevention campaigns, and workplace wellness initiatives that integrate sun safety as a core element of health promotion. For patients and caregivers, this could translate into clearer guidance, standardized product quality, and better access to effective sun protection.
Why BASF and Beyond Suncare support the decision
BASF, a global chemical leader with a portfolio that includes active sunscreen ingredients and protective technologies, has long invested in research and development to improve UV protection. Beyond Suncare, a brand focused on accessible sun protection, emphasizes consumer-friendly formulations that balance efficacy with skin health and comfort. Together, their support for the WHO decision highlights a shared commitment to scalable, science-driven solutions that empower people to protect themselves from sun damage every day.
Advancements in sunscreen science and product accessibility
Recent advances in formulation science—from stable UV filters to water resistance and skin-nourishing ingredients—make high-SPF, broad-spectrum products both effective and tolerable for daily wear. The WHO listing encourages manufacturers to continue improving product safety, efficacy, and affordability, potentially accelerating the rollout of affordable sunscreens in underserved communities and schools.
What comes next for brands and consumers
For consumers, the WHO decision reinforces the importance of choosing broad-spectrum, high-SPF sunscreens and adhering to appropriate reapplication guidelines, especially during peak sun hours. For brands, it sets a higher bar for product quality and accessibility. Companies like BASF and Beyond Suncare may explore expanded distribution, partnerships with government programs, and educational campaigns to promote sun safety as a basic health right.
About BASF and Beyond Suncare
BASF is a global leader in chemistry with extensive experience in UV protection technologies, while Beyond Suncare focuses on accessible, evidence-based sun care solutions. Both organizations are committed to public health outcomes and responsible innovation, aligning with the WHO’s mission to improve health access worldwide.
Conclusion
The WHO’s addition of broad-spectrum sunscreen to the Essential Medicines list marks a pivotal step in integrating sun protection into universal health strategies. With support from BASF and Beyond Suncare, this decision has the potential to broaden access, normalize preventive care, and ultimately reduce the health burden of sun-related diseases.
